Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

ASPirin Intervention for the REDuction of Colorectal Cancer Risk

Research Group

Gastrointestinal and Other Cancers

Status

Active, not recruiting

NCT ID

NCT02394769

This research study is investigating the use of aspirin as a potential chemopreventive agent to reduce risk of colorectal cancer

Intervention

Placebo for Aspirin, Aspirin

Condition

Colorectal Cancer

Investigators

Andrew T Chan, MD, MPH

See list of participating sites